Navigation Links
QuickSTAT Announces Global Expansion Plan to Enhance Its Global Network and Cold Chain Logistics Capabilities for Life Sciences

New York, NY (PRWEB) November 14, 2014

As part of an ongoing global expansion plan, QuickSTAT is making significant investments in its network and logistics capabilities to meet the evolving world of modern cold chain and the complex requirements of the industry.

The expansion will support QuickSTAT’s ongoing focus on customized logistics and transportation, and includes opening new QuickSTAT Control Towers and enhancement of existing facilities. There will be an emphasis on Customer Service capabilities, to provide increased support in this increasingly complex environment. Temperature-controlled vehicles have been added to its fleet, providing additional Priority Ground Logistics Solutions.

Transportation experts specializing in Research/ Drug Development and Cold Chain Logistics from around the world have joined the QuickSTAT team, and will provide consultation on stringent regulatory compliance, specialized packaging, Dangerous Goods transport, as well as best solutions and routings, including solutions for emerging market areas.

As part of the the expansion, a Control Tower in France has been opened to support clients in the region, and a Control Tower in the UK has been expanded, both designed for GDP Quality. These QuickSTAT Control Towers will provide 24/7 transportation and logistics services, as well as in-transit storage for patient-clinical specimens, API, vaccines and investigational drugs, utilizing GDP principles and best practices. Investments in LATAM, APAC and Africa are under way.

“Our investment in an increased global footprint, the recruitment of top industry specialists, along with our market-leading IT platform that helps clients manage their clinical trials demonstrates our commitment to the Life Science community. We are very excited about the enhanced solutions and tools we can provide,” says Dominique Brown, COO, QuickSTAT.

About QuickSTAT
For 35 years, QuickSTAT has managed multinational biopharmaceutical clinical trial logistics for all phases of research and drug development, for all temperature ranges and life science products. QuickSTAT specializes in time and temperature shipping of clinical research samples, biologics, investigational drugs, clinical trial supplies, vaccines and dangerous goods, helping to bring important new drugs and medical protocols to market faster.

Read the full story at

Source: PRWeb
Copyright©2014 Vocus, Inc.
All rights reserved

Related biology technology :

1. QuickSTAT “Cold Chain Manager” Technology Solution Ensures Temperature Integrity for Clinical Trial and Drug Development Shipments
2. Robert Tungatt, Regulatory Compliance and Cold Chain Excellence Specialist Joins QuickSTAT
3. CannLabs Announces Third Quarter 2014 Results.
4. WuXi AppTec Announces Enhanced Genomics Services for Chinese Researchers
5. iLab Solutions Announces Herbert Auer as the New Director, European Business Operations
6. Rancho BioSciences Announces Manually Curated GEO Data Sets Are Now Available
7. Diplomat Announces 3rd Quarter Financial Results
8. Lycera Announces Research Showing Novel, Oral Immunotherapy Possesses Potent Single Agent Anti-Cancer Activity
9. WaferGen Bio-systems Announces Third Quarter 2014 Results
10. Prostate Management Diagnostics, Inc. Announces Series A Financing
11. BRASKEM announces 3Q14 Results
Post Your Comments:
(Date:3/27/2021)... ... March 24, 2021 , ... ... Life Sciences and Healthcare firms of all sizes, adds depth to its team ... specialist. Pardillo, who earned his doctorate in computational chemistry from Florida International University ...
(Date:3/27/2021)... ... March 24, 2021 , ... ABI Wellness, ... and reporting approach designed under CEO Mark Watson, today announced a webinar dedicated ... featuring guest speakers Dr. Cameron Clark, Neuropsychologist and Founder of Sharp Thinking, and ...
(Date:3/27/2021)... ... ... The Xtalks editorial team is pleased to announce the launch of the ... joined by editorial team members Ayesha Rashid, Sydney Perelmutter and Mira Nabulsi to discuss ... including insights from industry experts. , The Xtalks Life Science podcast will feature ...
(Date:3/23/2021)... Conn. (PRWEB) , ... March 23, 2021 , ... ... develops solutions for characterizing microbiome populations down to the strain level, recently unveiled ... applications. , Not all microbes are created equal: some are easy to ...
Breaking Biology Technology:
(Date:3/27/2021)... ... March 25, 2021 , ... Phlexglobal announced ... Planet Group, has selected Phlexglobal and its innovative regulatory SaaS software, PhlexSubmission, as ... a comprehensive review of five regulatory software companies, with the review team including ...
(Date:3/27/2021)... ... 25, 2021 , ... The 2021 Virtual Conference on Clinical Trial Supply-Europe ... More and more, clinical trial supply conferences are featuring speakers and forums that ... Asymmetrex’s founder and CEO, James L. Sherley, M.D., Ph.D., presented a talk ...
(Date:3/23/2021)... ... March 23, 2021 , ... G-CON Manufacturing (G-CON), the ... by Matica Biotechnology (Matica Bio), a contract development and manufacturing organization (CDMO) specializing ... the cleanroom build out for its new GMP production facility in College Station, ...
Breaking Biology News(10 mins):